de Bleser P J, Jannes P, van Buul-Offers S C, Hoogerbrugge C M, van Schravendijk C F, Niki T, Rogiers V, van den Brande J L, Wisse E, Geerts A
Laboratory for Cell Biology and Histology, Free University Brussels V.U.B., Belgium.
Hepatology. 1995 May;21(5):1429-37. doi: 10.1002/hep.1840210529.
Transforming growth factor beta (TGF-beta), a potent fibrogenic cytokine, is secreted in latent form. We examined which cell type in both normal and carbon tetrachloride (CCl4)-induced fibrotic rat liver bears surface type II IGF/mannose 6-phosphate (IGF-II/M6P) receptor, known to facilitate activation of TGF-beta. In addition, the role of the IGF-II/M6P receptor in activation of latent TGF-beta was investigated in a coculture system with sinusoidal endothelial cells. Northern hybridization analysis for IGF-II/M6P receptor messenger RNA (mRNA) was performed on total RNA of different isolated and purified liver cell types. In normal liver, cells expressed little IGF-II/M6P receptor mRNA. In fibrotic liver, we found significant expression only in fat-storing cells. The presence of IGF-II/M6P receptors was established by [125I]IGF-II binding assays on freshly isolated fat-storing cells from normal and CCl4-exposed rat livers. We found specific binding of [125I]IGF-II only on CCl4 exposed fat-storing cells. As determined by polyacrylamide gel electrophoresis after affinity labeling, the specific binding involved 220 kD type II IGF receptors. Scatchard analysis revealed the presence of 3,043 +/- 1,378 IGF-II/M6P high-affinity receptors/fat-storing cell, with a Kd of 387 = 165 pmol/L. With a mink lung epithelial cell (Mv1Lu) proliferation inhibition assay, inhibition of proliferation (a measure of active TGF-beta function) was determined using conditioned media of activated fat-storing cells, cocultures of fat-storing cells, and endothelial cells and pure endothelial cell cultures.(ABSTRACT TRUNCATED AT 250 WORDS)
转化生长因子β(TGF-β)是一种强效的促纤维化细胞因子,以潜伏形式分泌。我们研究了正常和四氯化碳(CCl4)诱导的纤维化大鼠肝脏中哪种细胞类型带有II型胰岛素样生长因子/甘露糖6-磷酸(IGF-II/M6P)受体,已知该受体可促进TGF-β的激活。此外,在与窦状内皮细胞的共培养系统中研究了IGF-II/M6P受体在潜伏TGF-β激活中的作用。对不同分离和纯化的肝细胞类型的总RNA进行了IGF-II/M6P受体信使核糖核酸(mRNA)的Northern杂交分析。在正常肝脏中,细胞几乎不表达IGF-II/M6P受体mRNA。在纤维化肝脏中,我们发现仅贮脂细胞中有明显表达。通过对来自正常和CCl4处理大鼠肝脏的新鲜分离的贮脂细胞进行[125I]IGF-II结合试验,确定了IGF-II/M6P受体的存在。我们发现[125I]IGF-II仅在CCl4处理的贮脂细胞上有特异性结合。亲和标记后通过聚丙烯酰胺凝胶电泳测定,特异性结合涉及220 kD的II型IGF受体。Scatchard分析显示,每个贮脂细胞存在3043±1378个IGF-II/M6P高亲和力受体,解离常数Kd为387 = 165 pmol/L。使用貂肺上皮细胞(Mv1Lu)增殖抑制试验,利用激活的贮脂细胞的条件培养基、贮脂细胞与内皮细胞的共培养物以及纯内皮细胞培养物来测定增殖抑制(活性TGF-β功能的一种度量)。(摘要截短于250字)